Journal article
Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)
Abstract
BackgroundOutcomes of therapeutic studies in diffuse cutaneous systemic sclerosis (dcSSc) have mainly been measured for specific organs, particularly the skin and lungs. A new composite response index in dcSSc (CRISS) has been developed for clinical trials. The goal of this study was to determine whether, in an observational dcSSc cohort, immunosuppression was associated with global disease improvement measured with the CRISS.MethodsWe …
Authors
Zheng B; Hudson M; Wang M; Baron M
Journal
Arthritis Research & Therapy, Vol. 22, No. 1,
Publisher
Springer Nature
Publication Date
December 2020
DOI
10.1186/s13075-020-02220-0
ISSN
1478-6354